SINGAPORE (Feb 27): OCBC Investment Research, Phillip Capital and UOB Kay Hian are maintaining their “buy” calls on Raffles Medical Group with a fair value estimate and target prices of $1.26, $1.32 and $1.32 respectively.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply